Rainer Storb, MD

Member and Head of Transplantation Biology Program
Clinical Research Division
Professor of Medicine, Oncology
University of Washington


University of Munich, 1957, Physikum
University of Freiburg, 1960, State Medical Examination
University of Freiburg, 1960, MD

Research Focus:

Transplantation biology; basic and translational research into the biology of allogeneic blood and marrow hematopoietic cell transplantation (HCT)

  • Developing radically different approaches for HCT that have minimal toxicity, do not ablate the marrow, and thus are safe enough to administer in the ambulatory care setting.
  • Extending treatment with HCT from related and unrelated donors to include elderly and medically infirm patients with advanced hematologic malignancies and eradicating underlying disease with immunologic graft-vs-tumor effects.
  • Applying minimal-intensity conditioning regimens to treat patients with serious non-malignant blood disorders, such as aplastic anemia, hemoglobinopathies and immune deficiency diseases, by allogeneic HCT.
  • Develop novel methods for preventing acute GVHD and treating chronic GVHD in animal models based on mechanistic studies.
  • Investigating graft-host tolerance by establishing transient mixed hematopoietic chimerism as a prelude for acceptance of solid organ transplants.

Clinical Expertise:

  • Allogeneic HCT for patients with advanced malignant and non-malignant blood disorders
  • Prevention of graft-vs-host disease

Related News

Rainer Storb, MD

Contact Information

(206) 667-4407
(206) 667-6124
Additional contact

Mail Stop: D1-100